XML 16 R6.htm IDEA: XBRL DOCUMENT v3.25.0.1
Consolidated Statements of Stockholders' Deficit - USD ($)
shares in Thousands, $ in Thousands
Total
Convertible Notes
The Mann Group L L C
Convertible Note Principal
Convertible Note Principal
The Mann Group L L C
Convertible Note Interest
The Mann Group L L C
Common Stock
Common Stock
Convertible Note Principal
Common Stock
Convertible Note Principal
The Mann Group L L C
Common Stock
Convertible Note Interest
The Mann Group L L C
Additional Paid-in Capital
Additional Paid-in Capital
Convertible Note Principal
Additional Paid-in Capital
Convertible Note Principal
The Mann Group L L C
Additional Paid-in Capital
Convertible Note Interest
The Mann Group L L C
Accumulated Other Comprehensive Income
Accumulated Deficit
Beginning Balance at Dec. 31, 2021 $ (209,349)         $ 2,515       $ 2,918,205         $ (3,130,069)
Beginning Balance (in shares) at Dec. 31, 2021           251,478                  
Net issuance of common stock associated with restricted stock units and stock options 319         $ 22       297          
Net issuance of common stock associated with restricted stock units and stock options (in shares)           2,242                  
Issuance of common stock pursuant to conversion notes   $ 9,596     $ 674     $ 39 $ 2     $ 9,557 $ 672    
Issuance of common stock pursuant to conversion notes (in shares)               3,838 237            
Issuance of at-the-market offering 19,790         $ 51       19,739          
Issuance of at-the-market offering (in shares)           5,060                  
Issuance costs associated with at-the-market offering (381)                 (381)          
Issuance of common stock under the employee stock purchase plan 2,082         $ 6       2,076          
Issuance of common stock under the employee stock purchase plan (in shares)           686                  
Issuance of common stock from market price stock purchase plan 684         $ 3       681          
Issuance of common stock from market price stock purchase plan (in shares)           252                  
Stock-based compensation expense 13,447                 13,447          
Net Income (Loss) (87,400)                           (87,400)
Ending Balance at Dec. 31, 2022 (250,538)         $ 2,638       2,964,293         (3,217,469)
Ending Balance (in shares) at Dec. 31, 2022           263,793                  
Net issuance of common stock associated with restricted stock units and stock options (10,162)         $ 41       (10,203)          
Net issuance of common stock associated with restricted stock units and stock options (in shares)           4,169                  
Issuance of common stock pursuant to conversion notes         222       $ 1       221    
Issuance of common stock pursuant to conversion notes (in shares)                 51            
Issuance of at-the-market offering 6,887         $ 15       6,872          
Issuance of at-the-market offering (in shares)           1,478                  
Issuance costs associated with at-the-market offering (108)                 (108)          
Issuance of common stock under the employee stock purchase plan 1,668         $ 5       1,663          
Issuance of common stock under the employee stock purchase plan (in shares)           507                  
Issuance of common stock from market price stock purchase plan 152                 152          
Issuance of common stock from market price stock purchase plan (in shares)           36                  
Stock-based compensation expense 17,649                 17,649          
Net Income (Loss) (11,938)                           (11,938)
Ending Balance at Dec. 31, 2023 (246,168)         $ 2,700       2,980,539         (3,229,407)
Ending Balance (in shares) at Dec. 31, 2023           270,034                  
Net issuance of common stock associated with restricted stock units and stock options (6,087)         $ 38       (6,125)          
Net issuance of common stock associated with restricted stock units and stock options (in shares)           3,746                  
Issuance of common stock pursuant to conversion notes     $ 116,439 $ 3,750 $ 56   $ 267 $ 15     $ 11,617 $ 3,735 $ 56    
Issuance of common stock pursuant to conversion notes (in shares)             26,750 1,500 15            
Issuance of common stock under the employee stock purchase plan 1,778         $ 5       1,773          
Issuance of common stock under the employee stock purchase plan (in shares)           499                  
Issuance of common stock from market price stock purchase plan 1,361         $ 4       1,357          
Issuance of common stock from market price stock purchase plan (in shares)           416                  
Stock-based compensation expense 21,358                 21,358          
Unrealized gain on available-for-sale securities 1,109                         $ 1,109  
Net Income (Loss) 27,588                           27,588
Ending Balance at Dec. 31, 2024 $ (78,816)         $ 3,029       $ 3,118,865       $ 1,109 $ (3,201,819)
Ending Balance (in shares) at Dec. 31, 2024           302,960